NASDAQ:CMMB

Chemomab Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy CMMB

*Your capital is at risk

$1.72

-0.0200 (-1.15%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CMMB Prediction Chart

CMMB Predictions History

Latest community submissions for CMMB.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
JS Pro	Jul 19, 2021	$18.92 +4.88%	$18.04	X	95.12%
audisonsexto2	Jul 19, 2021	$21.00 +16.41%	$18.04	X	83.59%
mainostoimistokuopio.243480	Jun 14, 2021	$32.00 +45.06%	$22.06	X	54.94%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CMMB with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CHEMOMAB THERAPEUTICS LTD.

Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and cha...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by